Literature DB >> 18340512

Treatment of double carcinoma of the esophagus and lung.

Hiromichi Ishii1, Hiroshi Sato, Yasuhiro Tsubosa, Haruhiko Kondo.   

Abstract

We report four cases of double carcinoma of the esophagus and the lung. Case 1: a patient with synchronous double carcinoma of the esophagus and the lung underwent chemoradiotherapy (CRT) because of respiratory dysfunction. Case 2: a patient who was diagnosed with esophageal carcinoma after the surgery for lung carcinoma underwent CRT because of respiratory dysfunction. Case 3: a patient with synchronous double carcinoma underwent a two-stage operation. Case 4: a patient with synchronous double carcinoma underwent CRT at another hospital. To further treat the patients, we chose a two-stage operation. CRT is believed to be a feasible treatment in inoperable patients because patients 1 and 2 are alive 28 and 21 months after CRT, respectively. A two-stage operation is considered a suitably safe surgical procedure because no fatal postoperative complications occurred in cases 3 and 4.

Entities:  

Mesh:

Year:  2008        PMID: 18340512     DOI: 10.1007/s11748-007-0200-0

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  8 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus.

Authors:  Shuichi Hironaka; Atsushi Ohtsu; Narikazu Boku; Manabu Muto; Fumio Nagashima; Hiroki Saito; Shigeaki Yoshida; Mitsuyo Nishimura; Masatora Haruno; Satoshi Ishikura; Takashi Ogino; Seiichiro Yamamoto; Atsushi Ochiai
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-10-01       Impact factor: 7.038

Review 3.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.

Authors:  N P Rowell; C J Williams
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

4.  Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.

Authors:  Kazunari Yamada; Masao Murakami; Yoshiaki Okamoto; Yoshishige Okuno; Toshifumi Nakajima; Fusako Kusumi; Hiroshi Takakuwa; Satoru Matsusue
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-15       Impact factor: 7.038

5.  Surgical treatment of cancer of the thoracic esophagus in association with a major pulmonary operation.

Authors:  T Matsubara; M Ueda; T Takahashi; T Nakajima; M Nishi
Journal:  J Am Coll Surg       Date:  1997-12       Impact factor: 6.113

6.  Development of synchronous bilateral lung cancers after esophagectomy for esophageal cancer: report of a case.

Authors:  T Imada; H Sato; K Hasuo; A Nagano
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

7.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis.

Authors:  M Noguchi; A Morikawa; M Kawasaki; Y Matsuno; T Yamada; S Hirohashi; H Kondo; Y Shimosato
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

8.  Associated primary esophageal and lung carcinoma: a study of 39 patients.

Authors:  F Fékété; A Sauvanet; G Kaisserian; B Jauffret; K Zouari; L Berthoux; J F Flejou
Journal:  Ann Thorac Surg       Date:  1994-09       Impact factor: 4.330

  8 in total
  1 in total

1.  Minimally invasive resection of synchronous triple primary tumors of the esophagus, lung, and thymus: A case report.

Authors:  Xiao Song; Haibo Shen; Jie Li; Fengmin Wang
Journal:  Int J Surg Case Rep       Date:  2016-10-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.